|
1
|
Wang W, Zhang L, Liu L, Zheng Y, Zhang Y,
Yang S, Shi R and Wang S: Chemosensitizing effect of shRNA-mediated
ERCC1 silencing on a Xuanwei lung adenocarcinoma cell line and its
clinical significance. Oncol Rep. 37:1989–1997. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rojas A, Zhang P, Wang Y, Foo WC, Muñoz
NM, Xiao L, Wang J, Gores GJ, Hung MC and Blechacz B: A positive
TGF-β/c-KIT feedback loop drives tumor progression in advanced
primary liver cancer. Neoplasia. 18:371–386. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Baskar R, Yap SP, Chua KL and Itahana K:
The diverse and complex roles of radiation on cancer treatment:
Therapeutic target and genome maintenance. Am J Cancer Res.
2:372–382. 2012.PubMed/NCBI
|
|
4
|
Lee DH, Ahn Y, Kim SU, Wang KC, Cho BK,
Phi JH, Park IH, Black PM, Carroll RS, Lee J and Kim SK: Targeting
rat brainstem glioma using human neural stem cells and human
mesenchymal stem cells. Clin Cancer Res. 15:4925–4934. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ciavarella S, Dominici M, Dammacco F and
Silvestris F: Mesenchymal stem cells: A new promise in anticancer
therapy. Stem Cells Dev. 20:1–10. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yang J, Miao Y, Chang Y, Zhang F, Wang Y
and Zheng S: Condition medium of HepG-2 cells induces the
transdifferentiation of human umbilical cord mesenchymal stem cells
into cancerous mesenchymal stem cells. Am J Transl Res.
8:3429–3438. 2016.PubMed/NCBI
|
|
7
|
Liao W, Zhong J, Yu J, Xie J, Liu Y, Du L,
Yang S, Liu P, Xu J, Wang J, et al: Therapeutic benefit of human
umbilical cord derived mesenchymal stromal cells in intracerebral
hemorrhage rat: Implications of anti-inflammation and angiogenesis.
Cell Physiol Biochem. 24:307–316. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhong YS, Lin N, Deng MH, Zhang FC, Tang
ZF and Xu RY: Deficient proliferation of bone marrow-derived
mesenchymal stem cells in patients with chronic hepatitis B viral
infections and cirrhosis of the liver. Dig Dis Sci. 55:438–445.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bieback K, Kem S, Kluter H and Eichler H:
Critical parameters for the isolation of mesenchymal stem cells
from umbilical cord blood. Stem Cells. 22:625–634. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shen CJ, Chan TF, Chen CC, Hsu YC, Long CY
and Lai CS: Human umbilical cord matrix-derived stem cells
expressing interferon-β gene inhibit breast cancer cells via
apoptosis. Oncotarget. 7:34172–34179. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma S, Liang S, Jiao H, Chi L, Shi X, Tian
Y, Yang B and Guan F: Human umbilical cord mesenchymal stem cells
inhibit C6 glioma growth via secretion of dickkopf-1 (DKK1). Mol
Cell Biochem. 385:277–286. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang C, Lei D, Ouyang W, Ren J, Li H, Hu J
and Huang S: Conditioned media from human adipose tissue-derived
mesenchymal stem cells and umbilical cord-derived mesenchymal stem
cells efficiently induced the apoptosis and differentiation in
human glioma cell lines in vitro. Biomed Res Int. 2014:1093892014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang M, Cai J, Huang F, Zhu M, Zhang Q,
Yang T, Zhang X, Qian H and Xu W: Pre-treatment of human umbilical
cord-derived mesenchymal stem cells with interleukin-6 abolishes
their growth-promoting effect on gastric cancer cells. Int J Mol
Med. 35:367–375. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang X, Li Z, Ma Y, Gao J, Liu S, Gao Y
and Wang G: Human umbilical cord mesenchymal stem cells promote
carcinoma growth and lymph node metastasis when co-injected with
esophageal carcinoma cells in nude mice. Cancer Cell Int.
14:932014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yuan Y, Lu X, Chen X, Shao H and Huang S:
Jagged1 contributes to the drug resistance of Jurkat cells in
contact with human umbilical cord-derived mesenchymal stem cells.
Oncol Lett. 6:1000–1006. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qiao L, Xu ZL, Zhao TJ, Ye LH and Zhang
XD: Dkk-1 secreted by mesenchymal stem cells inhibits growth of
breast cancer cells via depression of Wnt signalling. Cancer Lett.
269:67–77. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ba Q, Li J, Huang C, Qiu H, Li J, Chu R,
Zhang W, Xie D, Wu Y and Wang H: Effects of benzo [a]pyrene
exposure on human hepatocellular carcinoma cell angiogenesis,
metastasis and NF-κB signaling. Environ Health Perspect.
123:246–254. 2015.PubMed/NCBI
|
|
18
|
Tian LL, Yue W, Zhu F, Li S and Li W:
Human mesenchymal stem cells play a dual role on tumor cell growth
in vitro and in vivo. J Cell Physiol. 226:1860–1867. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wei HJ, Nickoloff JA, Chen WH, Liu HY, Lo
WC, Chang YT, Yang PC, Wu CW, Williams DF, Gelovani JG and Deng WP:
FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming
of lung cancer cells. Oncotarget. 5:9514–9529. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, Fan H, Zhou B, Ju Z, Yu L, Guo L,
Han J and Lu S: Fusion of human umbilical cord mesenchymal stem
cells with esophageal carcinoma cells inhibits the tumorigenicity
of esophageal carcinoma cells. Int J Oncol. 40:370–377.
2012.PubMed/NCBI
|
|
21
|
Di GH, Jiang S, Li FQ, Sun JZ, Wu CT, Hu X
and Duan HF: Human umbilical cord mesenchymal stromal cells
mitigate chemotherapy-associated tissue injury in a pre-clinical
mouse model. Cytotherapy. 14:412–422. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang C, Yang SJ, Wen Q, Zhong JF, Chen
XL, Stucky A, Press MF and Zhang X: Human-derived normal
mesenchymal stem/stromal cells in anticancer therapies. J Cancer.
8:85–96. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma Y, Hao X, Zhang S and Zhang J: The in
vitro and in vivo effects of human umbilical cord mesenchymal stem
cells on the growth of breast cancer cells. Breast Cancer Res
Treat. 133:473–485. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang Y, Wang J, Ren M, Li M, Chen D, Chen
J, Shi F, Wang X and Dou J: Gene therapy of ovarian cancer using
IL-21-secreting human umbilical cord mesenchymal stem cells in nude
mice. J Ovarian Res. 7:82014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Subramanian A, Shu-Uin G, Kae-Siang N,
Gauthaman K, Biswas A, Choolani M, Bongso A and Chui-Yee F: Human
umbilical cord wharton's jelly mesenchymal stem cells do not
transform to tumor-associated fibroblasts in the presence of breast
and ovarian cancer cells unlike bone marrow mesenchymal stem cells.
J Cell Biochem. 113:1886–1895. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cohen GM: Caspases: The executioners of
apoptosis. Biochem J. 326:1–16. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ghoshal A and Ghosh SS: Antagonizing
canonical Wnt signaling pathway by recombinant human sFRP4 purified
from E. coli and its implications in cancer therapy. Mol Cell
Biochem. 418:119–135. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wei Y, Shen N, Wang Z, Yang G, Yi B, Yang
N, Qiu Y and Lu J: Sorafenib sensitizes hepatocellular carcinoma
cell to cisplatin via suppression of Wnt/β-catenin signaling. Mol
Cell Biochem. 381:139–144. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Baek SH, Kioussi C, Briata P, Wang D,
Nguyen HD, Ohgi KA, Glass CK, Wynshaw-Boris A, Rose DW and
Rosenfeld MG: Regulated subset of G1 growth-control genes in
response to derepression by the Wnt pathway. Proc Natl Acad Sci
USA. 100:3245–3250. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu J, Han G, Liu H and Qin C: Suppression
of cholangiocarcinoma cell growth by human umbilical cord
mesenchymal stem cells: A possible role of Wnt and Akt signaling.
PLoS One. 8:e628442013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Caplan AI and Correa D: The MSC: An injury
drugstore. Cell Stem Cell. 9:11–15. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Aguirre-Ghiso JA: Models, mechanisms and
clinical evidence for cancer dormancy. Nat Rev Cancer. 7:834–846.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Barkan D, El Touny LH, Michalowski AM,
Smith JA, Chu I, Davis AS, Webster JD, Hoover S, Simpson RM,
Gauldie J and Green JE: Metastatic growth from dormant cells
induced by a col-I-enriched fibrotic environment. Cancer Res.
70:5706–5716. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Almog N, Ma L, Raychowdhury R, Schwager C,
Erber R, Short S, Hlatky L, Vajkoczy P, Huber PE, Folkman J and
Abdollahi A: Transcriptional switch of dormant tumors to
fast-growing angiogenic phenotype. Cancer Res. 69:836–844. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Glick AB and Yuspa SH: Tissue homeostasis
and the control of the neoplastic phenotype in epithelial cancers.
Semin Cancer Biol. 15:75–83. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Alt-Holland A, Zhang W, Margulis A and
Garlick JA: Microenvironmental control of premalignant disease: The
role of intercellular adhesion in the progression of squamous cell
carcinoma. Semin Cancer Biol. 15:84–96. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
David DM and Goodridge HS: Information
processing during phagocytosis. Nat Rev Immuno. 12:492–502. 2012.
View Article : Google Scholar
|
|
38
|
Lavoie JR and Rosu-Myles M: Uncovering the
secretes of mesenchymal stem cells. Biochimie. 95:2212–2221. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jacobsen BM, Harrell JC, Jedlicka P,
Borges VF, Varella-Garcia M and Horwitz KB: Spontaneous fusion with
and transformation of mouse stroma by, malignant human breast
cancer epithelium. Cancer Res. 66:8274–8279. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mortensen K, Lichtenberg J, Thomsen PD and
Larsson LI: Spontaneous fusion between cancer cells and endothelial
cells. Cell Mol Life Sci. 61:2125–2131. 2004. View Article : Google Scholar : PubMed/NCBI
|
